Skip to content

Study · Animal study (in vivo) · rat · 2010

1 result

Antioxidant effect of carnosine pretreatment on cisplatin-induced renal oxidative stress in rats.

Noori S, Mahboob T

Indian journal of clinical biochemistry : IJCB1 Jan 2010Cited by 56 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Efficacy outcome

    In rats, carnosine reduced cisplatin-induced pathological changes in kidney tissue.

    In plain wordsIn rats, carnosine reduced kidney tissue damage compared with cisplatin treatment alone.

    Outcome
    DecreaseKidney pathological changes
    Study

    ratn = 12

    cisplatin-induced nephrotoxicity in male Albino Wistar rats
    Comparator
    cisplatin-treated rats
    Outcome group
    Kidney function · Kidney and urinary
    Studied dose
    10 mg/kgAs given in this study (rat).

    Source sentences

    Summary
    Carnosine reduced these pathological changes and counteracted the deleterious effects of cisplatin.
    3 context sentences
    Summary · context
    Marked elevation of kidney weight and reduced body weight and pathological changes in kidney tissues were also observed in Cisplatin-treated rats.
    Summary · context
    24 male Albino Wistar rats, were randomly divided into four groups (n=6).
    Summary · context
    Group I remains untreated; Group II received Cisplatin (3 mg / kg) for 5 alternate days; Group III received Carnosine (10 mg / kg) for consecutive 10 days; Group IV received Carnosine (10 mg / kg) before administration of Cisplatin (3 mg / kg).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    27 Oct 2026, 18:20 UTC

    Study results updated

  2. Version 1

    27 Oct 2026, 16:32 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.